Therefore, MERTK and its variants could act as central players in the control of apoptosis, immune response, HSC activation, and steatosis modulation, e.g., all factors involved in the pathogenesis of NAFLD and its fibrotic progression to steatohepatitis and cirrhosis. Here, MERTK is linked to Cirrhosis.